
Peter Frampton on His Diagnosis of Myositis; Ethical Perspectives on Costly Drugs and Healthcare
Neurology® Podcast
00:00
The Ethics of Drug Pricing
Eme: Our path to progress in drug pricing can't be driven just by pneurologists arguing about pharmaceutical company behavior. We need to find ways to make those prices more fair, but on the other hand, we want to recognize the importance of making sure that there's enough incentives for companies to continue to research and innovate. The views and opinions of the participants in this podcast do not necessarily reflect those of the journal neurology or the a a n.
Transcript
Play full episode